Stephen Hahn Should Focus on Stability in First Days As US FDA Commissioner, Stakeholders Say
December 18, 2019
Derrick Gingery
Pink Sheet
Axinn partner Chad Landmon was quoted in the Pink Sheet article, "Stephen Hahn Should Focus on Stability in First Days As US FDA Commissioner, Stakeholders Say."
Click here to access the article. A subscription is required.